Levels of HIAA and VMA in c.s.f. of schizophrenics before and after treatment.
D002395:Catecholamines / Q000037:antagonists & inhibitors; D018492:Dopamine Antagonists; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D008297:Male; D009292:Narcotic Antagonists; D009638:Norepinephrine / Q000378:metabolism; D012559:Schizophrenia / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000628:therapy; D012701:Serotonin / Q000378:metabolism; D014642:Vanilmandelic Acid / Q000134:cerebrospinal fluid*
D002395:Catecholamines; D018492:Dopamine Antagonists; D009292:Narcotic Antagonists; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D014642:Vanilmandelic Acid; D009638:Norepinephrine